(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) rose 9.06% to $3.25 at 10:47 EST on Friday, after five successive sessions in a row of losses. NASDAQ is rising 2.9% to $11,700.17, following the last session’s upward trend. This seems, so far, an all-around up trend exchanging session today.
TherapeuticsMD’s last close was $2.98, 8.36% above its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 165769 which is 28.16% below its average volume of 230772.
TherapeuticsMD’s sales growth is 33.7% for the ongoing quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 18.66%, a negative 5.97%, and a positive 7.04%, respectively.
TherapeuticsMD’s highest amplitude of average volatility was 18.66% (last week), 6.77% (last month), and 7.04% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be overbought (>=80).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $3.25 at 10:47 EST, way above its 52-week high of $2.75.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s value is way above its 50-day moving average of $0.66 and way higher than its 200-day moving average of $1.00.
More news about TherapeuticsMD (TXMD).